Items tagged with Global TB response
Progress on TB can be achieved in Africa (post)
1,450 people daily around the world. But this is not news to African countries, which are home to one third of the people globally who die from TB, even though they have less than one fifth of the world’s population.
- The news in many parts of the world is that tuberculosis (TB) is reclaiming the title of the world’s most deadly infection, even as the COVID-19 pandemic continues to kill an estimatedTransformative solutions for equitable access to TB services for persons with disabilities (post)
On the 3rd of December every year, the world observes the International Day of Persons with Disabilities. This day aims to promote better understanding of issues faced by people with disabilities, and to mobilize support for their dignity, rights and well-being. This year’s theme “Transformative solutions for inclusive development: the role of innovation in fuelling an accessible and equitable world” calls for actions to tackle challenges affecting the lives of persons with disabilities through innovation and technology solutions for inclusive development.
December 2022 issue of Public Health Action now online (post)
Public Health Action is the peer-reviewed open access journal of The International Union Against Tuberculosis and Lung Disease. It communicates and reports new knowledge across all relevant areas of operational research including: infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance and disease outbreaks.
IJTLD December 2022 issue now online (post)
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
TB is once again the deadliest disease in Africa - what went wrong (post)
Effective tuberculosis (TB) treatment has been available for the past 60 years. But TB remains the leading cause of death from a single infectious agent. It ranks above HIV and AIDS and others. This is partly because of the impact of HIV co-infection among TB patients in places like Africa and emergency of MDR-XDR TB. Lack of both gender mainstreaming and reduction of stigma manifested by persistently lower reported cases among women that men is of continued concern.
Dignity, freedom, and justice for all people with TB everywhere (post)
12 December 2022: Today is Universal Health Coverage (UHC) Day, the annual rallying point for the growing movement towards health for all. UHC Day marks the anniversary of the United Nations’ historic and unanimous endorsement of universal health coverage in 2012. It comes just two days after Human Rights Day that is commemorated on 10 December each year, in recognition of the day the United Nations General Assembly adopted the Universal Declaration of Human Rights in 1948. Tuberculosis (TB), one of the world’s top infectious killers, overwhelmingly affects marginalized people and communities, who are often also faced with poverty, stigma and discrimination, and social exclusion. TB-related catastrophic costs impact a significant proportion of people with TB, pushing many of them further into poverty. People-centred, quality and timely services for prevention, diagnosis, treatment, and care for TB are a basic human right.
IJTLD January 2023 issue now online (post)
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
IJTLD February 2023 issue now online (post)
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
Innovation deficit: Funds for neglected diseases like TB are falling short (post)
NEW YORK (January 31, 2023)—The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcome the world’s deadliest neglected diseases remained woefully inadequate and largely stagnant. Specifically, global investments in tuberculosis (TB) research and development (R&D) totaled $723 million in 2021, comparable to last year’s total and far short of the $2.16 billion estimated by Stop TB Partnership as needed annually to develop and deliver the suite of drug regimens, vaccines, and diagnostics that can end the TB pandemic. TB is regaining its dubious distinction as the world’s deadliest infectious disease, with more than 10 million people afflicted and 1.6 million dying each year.
2023 TB HLM Affected Communities and Civil Society Coordination Hub: Deep dive calls (post)
The 2023 TB HLM Affected Communities and Civil Society Coordination Hub has been constituted to support and provide a platform for the affected communities and the civil society to engage with all processes of the upcoming 2023 UN High-Level Meeting on TB (TB HLM) scheduled for September this year in New York, USA. The Hub is hosted by the Global Fund Advocates Network (GFAN) and supported by the Stop TB Partnership.
Page 111 of 174 · Total posts: 0
←First 110 111 112 Last→